Literature DB >> 11034092

Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.

C Cahlin1, A Körner, H Axelsson, W Wang, K Lundholm, E Svanberg.   

Abstract

MCG 101 tumors were implanted sc. on wild-type C57 Bl and gene knockout mice to evaluate the role of host-produced cytokines [interleukin (IL)-6, IL-12, IFNgamma, tumor necrosis factor (TNF) receptor 1, and TNF receptor 2] to explain local tumor growth, anorexia, and carcass weight loss in a well-defined model with experimental cachexia. Indomethacin was provided in the drinking water to explore interactions between host and tumor-derived prostaglandins and proinflammatory cytokines for tumor growth. Wild-type tumor-bearing mice developed cachexia because of rapid tumor growth, which were both attenuated in IL-6 gene knockouts. Similar findings were observed after provision of anti-IL-6 to wild-type tumor-bearing mice. Alterations in food intake were not directly related to systemic IL-6 but rather secondarily to IL-6-dependent tumor growth. The absence of host-derived IL-12, IFN-gamma, or the TNF receptor 1 or receptor 2 gene did not attenuate tumor growth or improve subsequent cachexia. Thus, carcass weight loss was not improved by the omission of host cytokine (TNF-alpha, IL-12, or IFN-gamma) except for IL-6. Systemic indomethacin provision decreased plasma prostaglandin E2 in five of six groups of gene knockout tumor-bearing mice, which was associated with improved carcass weight in these groups. Indomethacin seemed to improve food intake to a similar extent in both wild-type and gene knockouts, which agree with the speculation that eicosanoids are more important to explain anorexia than host cytokines. Our results demonstrate that host- and tumor-derived cytokines and prostaglandins interact with tumor growth and promote cachexia in a more complex fashion than usually presented based on previous information in studies on either anti-cytokine experiments in vivo or on gene knockouts with respect to a "single cytokine model." Overall, host cytokines were quantitatively less important than tumor-derived cytokines to explain net tumor growth, which indirectly explains subsequent cachexia and anorexia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034092

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis.

Authors:  Marek Wagner; Rolf Bjerkvig; Helge Wiig; Juan M Melero-Martin; Ruei-Zeng Lin; Michael Klagsbrun; Andrew C Dudley
Journal:  Angiogenesis       Date:  2012-05-22       Impact factor: 9.596

Review 2.  Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Authors:  Andrew Schrepf; Susan K Lutgendorf; Leah M Pyter
Journal:  Brain Behav Immun       Date:  2015-05-06       Impact factor: 7.217

Review 3.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNFα) blunt the response of Neuropeptide Y/Agouti-related peptide (NPY/AgRP) glucose inhibited (GI) neurons to decreased glucose.

Authors:  Lihong Hao; Zhenyu Sheng; Joseph Potian; Adam Deak; Christine Rohowsky-Kochan; Vanessa H Routh
Journal:  Brain Res       Date:  2016-07-26       Impact factor: 3.252

5.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

Review 6.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Influence of body mass index on survival in veterans with multiple myeloma.

Authors:  Tracey S Beason; Su-Hsin Chang; Kristen M Sanfilippo; Suhong Luo; Graham A Colditz; Ravi Vij; Michael H Tomasson; John F Dipersio; Keith Stockerl-Goldstein; Arun Ganti; Tanya Wildes; Kenneth R Carson
Journal:  Oncologist       Date:  2013-09-18

8.  Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial.

Authors:  Aminah Jatoi; James Egner; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; Shaker R Dakhil; James A Mailliard; George G Klee; James E Krook
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

9.  Role of NF-kappaB and cytokine in experimental cancer cachexia.

Authors:  Wei Zhou; Zhi-Wei Jiang; Jie Tian; Jun Jiang; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Global tumor RNA expression in early establishment of experimental tumor growth and related angiogenesis following COX-inhibition evaluated by microarray analysis.

Authors:  Hans Axelsson; Christina Lönnroth; Marianne Andersson; Wenhua Wang; Kent Lundholm
Journal:  Cancer Inform       Date:  2007-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.